ALEMBIC GLOBAL HOLDING SA FDA Approval ANDA 211574

ANDA 211574

ALEMBIC GLOBAL HOLDING SA

FDA Drug Application

Application #211574

Application Sponsors

ANDA 211574ALEMBIC GLOBAL HOLDING SA

Marketing Status

None (Tentative Approval)001
Prescription002
Prescription003
Prescription004

Application Products

001INJECTABLE;IV (INFUSION), SUBCUTANEOUS1MG/ML0TREPROSTINILTREPROSTINIL
002INJECTABLE;IV (INFUSION), SUBCUTANEOUS2.5MG/ML0TREPROSTINILTREPROSTINIL
003INJECTABLE;IV (INFUSION), SUBCUTANEOUS5MG/ML0TREPROSTINILTREPROSTINIL
004INJECTABLE;IV (INFUSION), SUBCUTANEOUS10MG/ML0TREPROSTINILTREPROSTINIL

FDA Submissions

UNKNOWN; ORIG1TA2020-09-03STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAP
002PrescriptionAP
003PrescriptionAP
004PrescriptionAP

CDER Filings

ALEMBIC GLOBAL HOLDING SA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211574
            [companyName] => ALEMBIC GLOBAL HOLDING SA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TREPROSTINIL","activeIngredients":"TREPROSTINIL","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/03\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-03
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.